visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Galectin Therapeutics

    Get Full Access

    Description

    • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
    • location

      Headquarters:4960 Peachtree Industrial Boulevard Suite 240, Norcross, Georgia, United States

      More
    • Galectin Therapeutics phone

      Phone Number: +1 617-559-0033

    • Galectin Therapeutics website

      Website: https://www.galectintherapeutics.com

    • Galectin Therapeutics employees

      Employees:37

    • Galectin Therapeutics revenue

      Revenue:$1 - 10M

    • Galectin Therapeutics legal name

      Legal Name:Galectin Therapeutics

    • Galectin Therapeutics's Social Media

      Galectin Therapeutics linkedin Galectin Therapeutics twitter
    • done Is this data correct?

    • |  NAICS Code: 325412  |

        NYSE: GALT

      Show More
    Person level website identification

    CEO for Galectin Therapeutics

    Joel Lewis

    Chief Executive Officer And President

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Jack Callicutt

    Chief Financial Officer

    Maureen Foley

    Chief Operating Officer

    Pol Boudes

    Chief Medical Officer

    Fahri Kaya

    Co-Owner

    Jim Czirr

    Ex Vice President Corp Management

    Frequently Asked Questions regarding Galectin Therapeutics

    • Where are Galectin Therapeutics's Headquarters?

      Galectin Therapeutics's Headquarters are in 4960 Peachtree Industrial Boulevard Suite 240,Norcross,Georgia,United States

    • What is Galectin Therapeutics's phone number?

      Galectin Therapeutics's phone number is +1 617-559-0033

    • What is Galectin Therapeutics's stock symbol?

      Galectin Therapeutics's stock symbol is GALT

    • What is Galectin Therapeutics's official website?

      Galectin Therapeutics's official website is https://www.galectintherapeutics.com

    • What is Galectin Therapeutics's Revenue?

      Galectin Therapeutics's revenue is $1 - 10M

    • What is Galectin Therapeutics's NAICS code?

      Galectin Therapeutics's NAICS code is 325412

    • How many employees are working in Galectin Therapeutics

      Galectin Therapeutics has 37 employees

    • What is Galectin Therapeutics's Industry?

      Galectin Therapeutics is in the industry of Pharmaceuticals

    Company Directory